Clinical trial
Extension Protocol for Patients Previously Treated in Avapritinib Clinical Trials
NCT04825574 is registered in ClinicalTrials.gov with Blueprint Medicines Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extension Protocol for Patients Previously Treated in Avapritinib Clinical Trials
- Lead sponsor
- Blueprint Medicines Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 21, 2021
- Completion date
- November 23, 2023
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.